{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T10:31:20Z","timestamp":1793442680275,"version":"4.5.0"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018608","name":"High-end Foreign Experts Recruitment Plan of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015401","name":"Shaanxi Province Key Research and Development Projects","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015401","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jconrel.2026.115448","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T15:46:49Z","timestamp":1791992809000},"page":"115448","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"PB","title":["Phenylboronate hydrogel for administration route tailored dual-drug delivery to anterior and posterior ocular segments"],"prefix":"10.1016","volume":"399","author":[{"given":"Rui Xue","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei Jia","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijia","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yexuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.115448_bb0005","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1056\/NEJMra2216081","article-title":"Eye infections","volume":"389","author":"Durand","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2026.115448_bb0010","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s13346-016-0339-2","article-title":"A comprehensive insight on ocular pharmacokinetics","volume":"6","author":"Agrahari","year":"2016","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2026.115448_bb0015","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","article-title":"Ocular drug delivery","volume":"12","author":"Gaudana","year":"2010","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2026.115448_bb0020","series-title":"2024 Praxis Medical Insights-Clinical Guidlines Distilled for Evidence-Based Practice","article-title":"Post-cataract surgery eye drop regimen","author":"Insights","year":"2024"},{"key":"10.1016\/j.jconrel.2026.115448_bb0025","doi-asserted-by":"crossref","first-page":"432","DOI":"10.5935\/0034-7280.20160087","article-title":"Adherence assessment of eye drops in patients with glaucoma using 8 item Morisky Score: a cross sectional study","volume":"75","author":"Ribeiro","year":"2016","journal-title":"Rev. Bras. Oftalmol."},{"key":"10.1016\/j.jconrel.2026.115448_bb0030","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.ajo.2011.05.015","article-title":"A video study of drop instillation in both glaucoma and retina patients with visual impairment","volume":"152","author":"Hennessy","year":"2011","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2026.115448_bb0035","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.ophtha.2015.03.026","article-title":"The most common barriers to glaucoma medication adherence: a cross-sectional survey","volume":"122","author":"Newman-Casey","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jconrel.2026.115448_bb0040","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.preteyeres.2016.12.001","article-title":"Pharmacokinetic aspects of retinal drug delivery","volume":"57","author":"del Amo","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.jconrel.2026.115448_bb0045","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.drudis.2019.03.023","article-title":"Depot formulations to sustain periocular drug delivery to the posterior eye segment","volume":"24","author":"Agban","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2026.115448_bb0050","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s11095-007-9408-z","article-title":"Drug elimination kinetics following subconjunctival injection using dynamic contrast-enhanced magnetic resonance imaging","volume":"25","author":"Kim","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2026.115448_bb0055","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.exer.2005.08.007","article-title":"A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonide","volume":"82","author":"Robinson","year":"2006","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jconrel.2026.115448_bb0060","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/s41433-020-0809-0","article-title":"Advances in ocular drug delivery systems","volume":"34","author":"Kang-Mieler","year":"2020","journal-title":"Eye"},{"key":"10.1016\/j.jconrel.2026.115448_bb0065","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.drudis.2019.05.006","article-title":"Therapeutic implications of nanomedicine for ocular drug delivery","volume":"24","author":"Meng","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2026.115448_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114770","article-title":"Polymer- and lipid-based nanocarriers for ocular drug delivery: current status and future perspectives","volume":"196","author":"Han","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115448_bb0075","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.3390\/pharmaceutics15041235","article-title":"Clinical translation of long-acting drug delivery systems for posterior capsule opacification prophylaxis","volume":"15","author":"Li","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115448_bb0080","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1021\/acs.molpharmaceut.6b00445","article-title":"Prolonged ocular retention of mucoadhesive nanoparticle eye drop formulation enables treatment of eye diseases using significantly reduced dosage","volume":"13","author":"Liu","year":"2016","journal-title":"Mol. Pharm."},{"issue":"13","key":"10.1016\/j.jconrel.2026.115448_bb0085","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3390\/pharmaceutics13030322","article-title":"Safety and tolerability of topical ophthalmic triamcinolone acetonide-loaded liposomes formulation and evaluation of its biologic activity in patients with diabetic macular edema","volume":"2021","author":"Navarro-Partida","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115448_bb0090","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3390\/pharmaceutics15041094","article-title":"Overcoming treatment challenges in posterior segment diseases with biodegradable nano-based drug delivery systems","volume":"15","author":"Wu","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115448_bb0095","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jconrel.2015.01.001","article-title":"Light-responsive nanoparticle depot to control release of a small molecule angiogenesis inhibitor in the posterior segment of the eye","volume":"200","author":"Huu","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115448_bb0100","doi-asserted-by":"crossref","first-page":"7544","DOI":"10.1016\/j.biomaterials.2013.06.044","article-title":"Long-term suppression of ocular neovascularization by intraocular injection of biodegradable polymeric particles containing a serpin-derived peptide","volume":"34","author":"Shmueli","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.115448_bb0105","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1007\/s13346-024-01566-1","article-title":"In vivo evaluation of a nano-enabled therapeutic vitreous substitute for the precise delivery of triamcinolone to the posterior segment of the eye","volume":"14","author":"Naik","year":"2024","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2026.115448_bb0110","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ejphar.2005.02.019","article-title":"Subconjunctivally administered celecoxib-PLGA microparticles sustain retinal drug levels and alleviate diabetes-induced oxidative stress in a rat model","volume":"511","author":"Ayalasomayajula","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.115448_bb0115","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1167\/iovs.05-0531","article-title":"Single periocular injection of celecoxib-plga microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF and vascular leakage","volume":"47","author":"Amrite","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2026.115448_bb0120","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1211\/jpp.57.12.0005","article-title":"Size-dependent disposition of nanoparticles and microparticles following subconjunctival administration","volume":"57","author":"Amrite","year":"2005","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.115448_bb0125","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jconrel.2017.10.031","article-title":"Injectable hydrogels for ophthalmic applications","volume":"268","author":"Wang","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115448_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100901","article-title":"Extraocular, periocular, and intraocular routes for sustained drug delivery for glaucoma","volume":"82","author":"Kompella","year":"2021","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.jconrel.2026.115448_bb0135","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1080\/17425247.2016.1227785","article-title":"Extended ocular drug delivery systems for the anterior and posterior segments: biomaterial options and applications","volume":"14","author":"Kang-Mieler","year":"2017","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2026.115448_bb0145","doi-asserted-by":"crossref","first-page":"6674","DOI":"10.1021\/acs.chemmater.4c00507","article-title":"Boronate ester hydrogels for biomedical applications: challenges and opportunities","volume":"36","author":"Terriac","year":"2024","journal-title":"Chem. Mater."},{"key":"10.1016\/j.jconrel.2026.115448_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114470","article-title":"Boronate-crosslinked hydrogel enables localized chemoimmunotherapy to remodel the immune microenvironment in triple-negative breast cancer","volume":"389","author":"Liu","year":"2026","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115448_bb0155","article-title":"ROS-responsive hydrogel loaded with berberine liposome protects against intervertebral disc degeneration by inhibiting mitochondrial fission and apoptosis","volume":"522","author":"Guo","year":"2025","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.jconrel.2026.115448_bb0160","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s12668-026-02678-3","article-title":"Immunomodulatory phenylboronic acid-chitosan hydrogel integrated with \u03b2-cd\/curcumin for targeted conjunctivitis therapy","volume":"16","author":"Deng","year":"2026","journal-title":"BioNanoSci"},{"key":"10.1016\/j.jconrel.2026.115448_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.116845","article-title":"Boronate-Ester crosslinked hyaluronic acid hydrogels for dihydrocaffeic acid delivery and fibroblasts protection against UVB irradiation","volume":"247","author":"de Oliveira","year":"2020","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2026.115448_bb0170","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1021\/acs.biomac.7b01243","article-title":"Autonomously self-adhesive hydrogels as building blocks for additive manufacturing","volume":"19","author":"Deng","year":"2018","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2026.115448_bb0175","doi-asserted-by":"crossref","first-page":"11385","DOI":"10.1021\/acs.chemrev.0c01177","article-title":"Translational applications of hydrogels","volume":"121","author":"Correa","year":"2021","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2026.115448_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2020.102342","article-title":"Strategies to prolong the residence time of drug delivery systems on ocular surface","volume":"288","author":"Grassiri","year":"2021","journal-title":"Adv. Colloid Interf. Sci."},{"key":"10.1016\/j.jconrel.2026.115448_bb0185","doi-asserted-by":"crossref","first-page":"915","DOI":"10.7150\/thno.103266","article-title":"Advances in adhesive hydrogels applied for ophthalmology: an overview focused on the treatment","volume":"15","author":"Yan","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2026.115448_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.comptc.2021.113249","article-title":"Shermo: a general code for calculating molecular thermochemistry properties","volume":"1200","author":"Lu","year":"2021","journal-title":"Comput. Theor. Chem."},{"key":"10.1016\/j.jconrel.2026.115448_bb0195","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/jcc.22885","article-title":"Multiwfn: a multifunctional wavefunction analyzer","volume":"33","author":"Lu","year":"2012","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jconrel.2026.115448_bb0200","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1021\/ct700248k","article-title":"Performance of B3lLYP density functional methods for a large set of organic molecules","volume":"4","author":"Tirado-Rives","year":"2008","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.jconrel.2026.115448_bb0205","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1016\/j.biomaterials.2011.12.050","article-title":"The mechanical properties and cytotoxicity of cell-laden double-network hydrogels based on photocrosslinkable gelatin and gellan gum biomacromolecules","volume":"33","author":"Shin","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.115448_bb0210","series-title":"Ocular Anti-Infection Liposomal Formulation and Preparation Method and Thereof (China, Patent No.: ZL2023 1 0214627.6, China National Intellectual Property Administration, Active)","author":"Yan","year":"2024"},{"key":"10.1016\/j.jconrel.2026.115448_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2023.104629","article-title":"Depot unilamellar liposomes to sustain transscleral drug co-delivery for ophthalmic infection therapy","volume":"86","author":"Su","year":"2023","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.jconrel.2026.115448_bb0220","series-title":"Nanoparticle-Hydrogel for Controllable Degradation and Preparation Method and Thereof (China, Patent No.: ZL2022 1 1000324.6, China National Intellectual Property Administration, Active)","author":"Yan","year":"2023"},{"key":"10.1016\/j.jconrel.2026.115448_bb0225","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2147\/LRA.S16314","article-title":"Sub-Tenon's anesthesia: an update, local","volume":"5","author":"Guise","year":"2012","journal-title":"Reg. Anesth."},{"key":"10.1016\/j.jconrel.2026.115448_bb0230","series-title":"Fundamentals of Toxicologic Pathology","year":"2018"},{"key":"10.1016\/j.jconrel.2026.115448_bb0235","author":"National Medical Products Administration"},{"key":"10.1016\/j.jconrel.2026.115448_bb0240","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ijpharm.2008.02.017","article-title":"Boronate-containing polymers form affinity complexes with mucin and enable tight and reversible occlusion of mucosal lumen by poly(vinyl alcohol) gel","volume":"358","author":"Ivanov","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.115448_bb0245","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1021\/bm800276d","article-title":"Why is chitosan mucoadhesive?","volume":"9","author":"Sogias","year":"2008","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2026.115448_bb0250","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cmpb.2010.01.007","article-title":"Pksolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in microsoft excel","volume":"99","author":"Zhang","year":"2010","journal-title":"Comput. Methods Prog. Biomed."},{"key":"10.1016\/j.jconrel.2026.115448_bb0255","author":"Merck"},{"key":"10.1016\/j.jconrel.2026.115448_bb0260","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/bjo.86.2.181","article-title":"Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye","volume":"86","author":"Aragona","year":"2002","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2026.115448_bb0265","doi-asserted-by":"crossref","first-page":"22064","DOI":"10.1021\/acsami.6b07433","article-title":"\"Click\" chemistry-tethered hyaluronic acid-based contact lens coatings improve lens wettability and lower protein adsorption","volume":"8","author":"Deng","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2026.115448_bb0270","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jconrel.2021.06.011","article-title":"Ocular drug delivery to the anterior segment using nanocarriers: a mucoadhesive\/mucopenetrative perspective","volume":"336","author":"Dave","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115448_bb0275","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ejpb.2015.05.016","article-title":"Hydrogels in ophthalmic applications","volume":"95","author":"Kirchhof","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2026.115448_bb0280","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1590\/S0004-27492007000200004","article-title":"Use conditions of boric acid solution in the eye: handling and occurrence of contamination","volume":"70","author":"Jos\u00e9","year":"2007","journal-title":"Arq. Bras. Oftalmol."},{"key":"10.1016\/j.jconrel.2026.115448_bb0285","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jtos.2016.03.003","article-title":"Ocular surface membrane-associated mucins","volume":"14","author":"Ablamowicz","year":"2016","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.jconrel.2026.115448_bb0290","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/mabi.201000388","article-title":"Advances in mucoadhesion and mucoadhesive polymers","volume":"11","author":"Khutoryanskiy","year":"2011","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.jconrel.2026.115448_bb0295","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0014-4835(03)00204-5","article-title":"Distribution of mucins at the ocular surface","volume":"78","author":"Gipson","year":"2004","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jconrel.2026.115448_bb0300","doi-asserted-by":"crossref","first-page":"16071","DOI":"10.1038\/natrevmats.2016.71","article-title":"Designing hydrogels for controlled drug delivery","volume":"1","author":"Li","year":"2016","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2026.115448_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2025.107380","article-title":"Liposomes-in-hydrogel for topical drug delivery: mechanical, kinetic, and biological insights","volume":"113","author":"Braido","year":"2025","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.jconrel.2026.115448_bb0310","doi-asserted-by":"crossref","DOI":"10.1007\/s13346-026-02095-9","article-title":"Rectal nanoparticulate-hydrogel delivering budesonide to reduce enterohepatic drug metabolism and clearance","author":"Zhang","year":"2026","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2026.115448_bb0315","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202507209","article-title":"Recent developments in nanoparticle-hydrogel hybrid materials for controlled release","volume":"12","author":"Fan","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.115448_bb0320","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3390\/gels10090589","article-title":"Exploring hydrogel nanoparticle systems for enhanced ocular drug delivery","volume":"10","author":"Arabpour","year":"2024","journal-title":"Gels"},{"key":"10.1016\/j.jconrel.2026.115448_bb0330","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jconrel.2020.11.053","article-title":"In vivo fate of liposomes after subconjunctival ocular delivery","volume":"329","author":"Chaw","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115448_bb0335","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3390\/gels7040255","article-title":"Relationship between structure and rheology of hydrogels for various applications","volume":"7","author":"Stojkov","year":"2021","journal-title":"Gels"},{"key":"10.1016\/j.jconrel.2026.115448_bb0340","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ijpharm.2018.11.012","article-title":"Injectability as a function of viscosity and dosing materials for subcutaneous administration","volume":"554","author":"Watt","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.115448_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2024.113884","article-title":"Mucoadhesive phenylboronic acid-grafted carboxymethyl cellulose hydrogels containing glutathione for treatment of corneal epithelial cells exposed to benzalkonium chloride","volume":"238","author":"Cheng","year":"2024","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2026.115448_bb0350","first-page":"455","article-title":"Development of phenylboronic acid containing mucoadhesive hydrogel materials for ophthalmic drug delivery applications","volume":"55","author":"Liu","year":"2014","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2026.115448_bb0355","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s12274-014-0547-3","article-title":"Phenylboronic acid modified mucoadhesive nanoparticle drug carriers facilitate weekly treatment of experimentallyinduced dry eye syndrome","volume":"8","author":"Liu","year":"2015","journal-title":"Nano Res."},{"key":"10.1016\/j.jconrel.2026.115448_bb0360","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1021\/acs.biomac.6b00054","article-title":"Phenylboronic-acid-based polymeric micelles for mucoadhesive anterior segment ocular drug delivery","volume":"17","author":"Prosperi-Porta","year":"2016","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2026.115448_bb0365","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jconrel.2010.08.028","article-title":"Barrier analysis of periocular drug delivery to the posterior segment","volume":"148","author":"Ranta","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115448_bb0370","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1167\/iovs.07-0593","article-title":"Modeling of corneal and retinal pharmacokinetics after periocular drug administration","volume":"49","author":"Amrite","year":"2008","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2026.115448_bb0375","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5301\/EJO.2010.6049","article-title":"Blood-retinal barrier","volume":"21","author":"Cunha-Vaz","year":"2011","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2026.115448_bb0380","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.jconrel.2020.10.028","article-title":"Ocular barriers to retinal delivery of intravitreal liposomes: impact of vitreoretinal interface","volume":"328","author":"Tavakoli","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115448_bb0385","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/jop.2012.0138","article-title":"The vitreous humor as a barrier to nanoparticle distribution","volume":"29","author":"Mains","year":"2013","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2026.115448_bb0390","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jconrel.2013.01.018","article-title":"Nanoparticle diffusion in, and microrheology of, the bovine vitreous ex vivo","volume":"167","author":"Xu","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115448_bb0395","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1517\/17425247.1.1.99","article-title":"Periocular routes for retinal drug delivery","volume":"1","author":"Raghava","year":"2004","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2026.115448_bb0400","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0014-4835(03)00212-4","article-title":"Scleral structure, organisation and disease. A review","volume":"78","author":"Watson","year":"2004","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jconrel.2026.115448_bb0405","series-title":"Pharmacology of the Eye","first-page":"19","article-title":"Ocular pharmacokinetics","author":"Maurice","year":"1984"},{"key":"10.1016\/j.jconrel.2026.115448_bb0410","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.addr.2006.07.027","article-title":"Challenges and obstacles of ocular pharmacokinetics and drug delivery","volume":"58","author":"Urtti","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115448_bb0415","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1021\/js9802594","article-title":"Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye","volume":"87","author":"Prausnitz","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2026.115448_bb0420","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4103\/ijo.IJO_646_17","article-title":"Anatomy of cornea and ocular surface","volume":"66","author":"Sridhar","year":"2018","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2026.115448_bb0425","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2147\/OPTH.S1666","article-title":"Review of moxifloxacin hydrocholoride ophthalmic solution in the treatment of bacterial eye infections","volume":"2","author":"Miller","year":"2008","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.jconrel.2026.115448_bb0430","series-title":"Product Monograph, Pr APO-MOXIFLOXACIN, Moxifloxacin Ophthalmic Solution USP 0.5% w\/v, APTEX INC. Control NO.: 222971, Revision: December 31, 2018","year":"2026"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926008527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926008527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T09:43:57Z","timestamp":1793439837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926008527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":84,"alternative-id":["S0168365926008527"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115448","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenylboronate hydrogel for administration route tailored dual-drug delivery to anterior and posterior ocular segments","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115448","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115448"}}